Growth Watch· Houston

Bristol Myers Squibb Commits $2.3B to a Generation Park Campus

A second pharmaceutical giant is building in northeast Houston, turning Generation Park into a real employment hub.

Photo coming from the company’s press kit, credited.

Key numbers
  • $2.3 billion manufacturing campus
  • Nearly 500 skilled jobs, plus about 2,000 construction and indirect jobs
  • Construction starts in 2027, operations by 2030
  • $4.89 million Texas Enterprise Fund grant

Bristol Myers Squibb announced on August 10 that it will build a $2.3 billion manufacturing campus at Generation Park, the 4,300-acre business district near Lake Houston.

What it will make

The site will produce several kinds of medicines, including small-molecule drugs, biologics and antibody-drug conjugates, from late-stage development through commercial launch. It is designed to be reconfigured and expanded as the company’s pipeline changes.

Jobs and timing

The company expects nearly 500 skilled jobs to start, plus about 2,000 construction and indirect jobs between 2027 and 2030. Construction begins in 2027, with operations expected by 2030. The State of Texas awarded a $4.89 million Texas Enterprise Fund grant.

Next door to Lilly

Bristol Myers Squibb joins Eli Lilly, which broke ground on a $6.5 billion plant at Generation Park in September. The Greater Houston Partnership called the announcement a major win for the region.

Why it matters for Houston multifamily

Two major pharmaceutical employers side by side turn Generation Park into a lasting jobs hub.

Where we’re watching

Northeast Houston rentals around Generation Park, including Humble, Atascocita and Kingwood.

Report

Download the Houston Multifamily Report, Q3 2026

Map

See every Houston submarket on the map

Explore the map
Survey

Take the Houston Multifamily Pulse

Join the panel

Get Houston multifamily in five minutes, every two weeks.

Interested in investing in Houston multifamily with local, boots-on-the-ground operators?Learn more

Written by Price Per Door from public reports, filings and data. See all sources